Paradigm Biocapital Advisors LP
Related Filers (18)
- Olema Pharmaceuticals, Inc. (5)
- Viridian Therapeutics, Inc.\DE (4)
- Vor Biopharma Inc. (3)
- ALPINE IMMUNE SCIENCES, INC. (3)
- Oyster Point Pharma, Inc. (2)
- BICYCLE THERAPEUTICS plc (2)
- Autolus Therapeutics plc (2)
- Arcellx, Inc. (2)
- Disc Medicine, Inc. (2)
- Nuvalent, Inc. (2)
- Paradigm BioCapital International Fund Ltd. (2)
- Asefaw Senai (2)
- Paradigm BioCapital Advisors GP LLC (2)
- Corbus Pharmaceuticals Holdings, Inc. (2)
- COMPASS Pathways plc (2)
- Ambrx Biopharma Inc. (1)
- Tarsus Pharmaceuticals, Inc. (1)
- Ambrx Biopharma, Inc. (1)
- Show More ...
Other (9)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (34)
SC 13G/A
Wednesday, 2/14/2024
Nuvalent, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
BICYCLE THERAPEUTICS plc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
COMPASS Pathways plc: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Corbus Pharmaceuticals Holdings, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Autolus Therapeutics plc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Vor Biopharma Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Ambrx Biopharma, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Arcellx, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Disc Medicine, Inc.: Major Shareholders
SC 13G
Monday, 2/5/2024
Corbus Pharmaceuticals Holdings, Inc.: Major Shareholders
SC 13G
Monday, 1/22/2024
Tarsus Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Tuesday, 1/2/2024
COMPASS Pathways plc: Major Shareholders
4
Friday, 12/8/2023
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/30/2023
Nuvalent, Inc.: Major Shareholders
SC 13G
Monday, 9/25/2023
Disc Medicine, Inc.: Major Shareholders
SC 13G
Monday, 9/25/2023
Ambrx Biopharma Inc.: Major Shareholders
3
Thursday, 9/21/2023
Olema Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Wednesday, 9/13/2023
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 7/21/2023
Arcellx, Inc.: Major Shareholders
SC 13G
Monday, 7/10/2023
Autolus Therapeutics plc: Major Shareholders
SC 13G
Thursday, 5/11/2023
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G
Monday, 4/10/2023
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 2/24/2023
BICYCLE THERAPEUTICS plc: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Oyster Point Pharma, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Vor Biopharma Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G
Thursday, 10/27/2022
Vor Biopharma Inc.: Major Shareholders
SC 13G
Monday, 10/3/2022
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13G
Monday, 7/18/2022
Oyster Point Pharma, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
Viridian Therapeutics, Inc.\DE: Major Shareholders